Product NDC: | 0378-2721 |
Proprietary Name: | Galantamine |
Non Proprietary Name: | Galantamine |
Active Ingredient(s): | 4 mg/1 & nbsp; Galantamine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-2721 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077590 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120619 |
Package NDC: | 0378-2721-91 |
Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-2721-91) |
NDC Code | 0378-2721-91 |
Proprietary Name | Galantamine |
Package Description | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-2721-91) |
Product NDC | 0378-2721 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Galantamine |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20120619 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | GALANTAMINE HYDROBROMIDE |
Strength Number | 4 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |